Norbert Riedel serves as an Advisory Board member for Cell Therapy Foundation. Norbert is Corporate Vice President and Chief Scientific Officer for Baxter and has served in that capacity since March 2001. Prior to joining Baxter, he was head of worldwide biotechnology and worldwide core research functions at Hoechst Marion Roussel, now Sanofi-Aventis. Norbert serves on the Board of Directors of Oscient Pharmaceuticals Corporation and Medigene AG. He is Chair of the Illinois Biotechnology Industry Organization and a member of the Advisory Board of Northwestern University's Kellogg School of Management Center for Biotechnology.